Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan
Azerbaijan: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage was 52.0% in 2024. ▼ Falling
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan, 2014–2024
Source: WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data. Measured in %.
Analysis
In 2024, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan stood at 52.0%.
The figure is unchanged over ten years.
Over the whole period, pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan peaked at 79.0% in 2015 and was at its lowest, 47.0%, in 2020.
Azerbaijan ranks 139th of 146 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 11 years of available data.
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan, year by year
| Year | % | Change |
|---|---|---|
| 2014 | 52.0% | — |
| 2015 | 79.0% | +51.9% |
| 2016 | 79.0% | +0.0% |
| 2017 | 74.0% | -6.3% |
| 2018 | 70.0% | -5.4% |
| 2019 | 66.0% | -5.7% |
| 2020 | 47.0% | -28.8% |
| 2021 | 50.0% | +6.4% |
| 2022 | 52.0% | +4.0% |
| 2023 | 52.0% | +0.0% |
| 2024 | 52.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 70.0% | 52.0% | 79.0% | 6 |
| 2020s | 50.6% | 47.0% | 52.0% | 5 |
Countries ranked near Azerbaijan
- 136 Afghanistan 57.0% compare
- 137 Slovenia 56.0% compare
- 138 Mozambique 55.0% compare
- 140 Haiti 45.0% compare
- 141 Central African Republic 42.0% compare
- 142 Papua New Guinea 41.0% compare
- 142 Yemen 41.0% compare
More health data for Azerbaijan
- Un projection of annual infant deaths, annual growth rate -1.12 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.1127 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,241 deaths per 1,000 people (2090)
- Number of infants who die before age 1 264 deaths (2100)
- Population ages 0-14, female, annual growth rate -2.37 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1004 units per person (2025)
- Population ages 0-14, male, annual growth rate -2.39 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1116 units per person (2025)
Frequently asked questions
- What is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan?
- Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage in Azerbaijan was 52.0% in 2024, according to WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data.
- What is the highest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Azerbaijan?
- The highest recorded value was 79.0% in 2015.
- What is the lowest pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage recorded in Azerbaijan?
- The lowest recorded value was 47.0% in 2020.
- How does Azerbaijan rank for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Azerbaijan ranks 139th out of 146 countries with data for 2024.
- Is pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage rising or falling in Azerbaijan?
- Over the last ten years it is unchanged. The long-run trend across the full record is falling.
- Where does this Azerbaijan data come from?
- The figures come from WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as part of Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 11 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.